What is the NOCEDP?

The NOCEDP is a clinical research program designed to identify those women who are atincreased risk for
developing ovarian cancer and to apply new research and tests, related to the ovaries, to help detect ovarian cancer at an early stage.

The program combines the expertise of gynecologic oncology, medical oncology, advanced-practice oncology nursing, genetics, ultrasonography, biochemistry, and molecular biology to offer a comprehensive early detection program for women at risk of developing ovarian cancer.

If you wish to participate in the program or want further information, call Dr. Fishman, 212-241-1901
NOCEDP is located at Mount Sinai School of Medicine.

Remember.. September is Ovarian Awareness Month!

Dr. David Fishman

_____________________________________________________________________________


Statistics for Ovarian Cancer:

- Approximately 24,000 women are diagnosed annually
- About 75% are diagnosed after the disease has spread (stages III and IV)
- 5 Year survial rate (due to late detection) has previously been 15% and is now approaching 25%
- Cases with an early diagnosis (stage I) have an overall 5 year survial rate approaching 90%

Symptoms of Ovarian Cancer:

- Fatigue
- Constant feeling of fullness + bloating
- Pelvic and/or abdominal pain and discomfort
- Pain during intercourse
- Abnormal or postmenopausal bleeding
- Unexplained weight loss or gain
- Unexplained change in bowel and/or bladder habits
- Gastrointestinal upset such as gas, indigestion or nausea

These symptoms and potential signs of ovarian cancer are vague or "silent". 
Only about 10% of these cancers are found in the early stages.

TO PARTICIPATE IN THE
NATIONAL OVARIAN CANCER
EARLY DETECTION PROGRAM,

which is designed to identify those women who are at risk for developing
ovarian cancer and to apply new research and tests to theovaries, to help detect ovarian cancer at an
early and treatable stage, call (212)241-1901 , (Doctor Fishman)
at the Mt Sinai School of Medicine. 

Tell them that you heard about them through VOICE, the Varadi Ovarian Initiative for Cancer Education.